{"certainAgreement":{"otherDetails":"The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"ClinicalTrialsDisclosure@merck.com","organization":"Merck Sharp & Dohme Corp.","phone":"1-800-672-6372","title":"Senior Vice President, Global Clinical Development"}}